Parkinson’s Disease (PD) remains the second most prevalent neurodegenerative disorder worldwide, yet it continues to evade a definitive disease-modifying ...

The sunbird Syn (TM) assay accurately classified Parkinson's disease-positive blood samples with 81% accuracy through the direct detection of EV-bound aggregated alpha-synuclein proteins -- -- With no ...

The joint study used deep brain stimulation devices to measure how 12 exercise sessions created new neural pathways in ...

The presentation builds on momentum from the Company’s recent Phase 3 PD biomarker data, showing that patients with amyloid ...

This story was commissioned by the River City Journalism Fund Mary Eagan, 71, stares at the body-height punching bag, her delicate hands buried in a pair of giant red boxing gloves. On this warm ...

For individuals recovering from neurological conditions such as stroke, traumatic brain injury (TBI), multiple sclerosis, ...

Cleveland researchers used innovative balloon game to motivate participants through cycling sessions that showed measurable changes in neural connections.

Parkinson's disease affects more than 1.1 million people in the United States, progressively damaging the brain cells that ...

Researchers in Australia have found that Parkinson's disease causes significant and progressive changes in the brain's blood ...

A new study of 11 million people found their odds of developing Parkinson's nearly doubled if they had sleep apnea that went ...

A large analysis of more than 11 million medical records found that people with untreated obstructive sleep apnea face a substantially higher risk of developing Parkinson’s disease over time.

Enigma Biomedical USA ( EB USA) today announced that The Michael J. Fox Foundation for Parkinson's Research (MJFF), has awarded EB USA $2 million for the discovery and initial preclinical development ...